RGEN 8-K 2026-09-15
REPLIGEN CORP (RGEN) 8-K dated 2026-09-15 — accession 0001628280-26-062043.
REPLIGEN CORP (RGEN) is a medical instruments & supplies company listed on NASDAQ.
REPLIGEN CORP filed a 8-K on 2026-09-15. Accession 0001628280-26-062043.
This 8-K covers: Director/officer change (Item 5.02). SEC EDGAR holds the official filing and its exhibits.
Latest reported RGEN revenue for 2025-12-31 was $738.3M. Net income was $48.9M. Revenue was up 16.4% from 2024-12-31 to 2025-12-31. RGEN currently screens at market cap $7.43B.
Not investment advice. The RGEN SEC hub lists recent forms. The stock page is the research view.